logo

CNTA

Centessa·NASDAQ
--
--(--)
--
--(--)
2.12 / 10
Underperform

CNTA's fundamental health is concerning (2.1/10). Key risks include high Days sales outstanding (72.55) and elevated PB-ROE, outweighing moderate positives like Interest coverage ratio (15.48) and revenue growth (92.66% YoY). This profile suggests limited near-term upside without operational improvements.

Fundamental(2.12)SentimentTechnical

Analysis Checks(6/10)

Revenue-MV
Value-0.26
Score1/3
Weight11.37%
1M Return4.24%
Total operating revenue (YoY growth rate %)
Value78.47
Score2/3
Weight2.42%
1M Return1.11%
Days sales outstanding
Value72.55
Score1/3
Weight-3.11%
1M Return-1.57%
Profit-MV
Value0.46
Score2/3
Weight22.58%
1M Return8.45%
Net income-Revenue
Value-0.17
Score2/3
Weight22.61%
1M Return8.45%
PB-ROE
Value6.15
Score0/3
Weight6.74%
1M Return2.72%
Interest coverage ratio (EBIT / Interest expense) (%)
Value15.48
Score2/3
Weight-2.26%
1M Return-1.11%
Operating revenue (YoY growth rate %)
Value92.66
Score2/3
Weight0.93%
1M Return0.43%
Asset-MV
Value-0.50
Score1/3
Weight16.52%
1M Return6.68%
Cash-MV
Value-0.07
Score2/3
Weight22.20%
1M Return8.41%
Is CNTA fundamentally strong?
  • CNTA scores 2.12/10 on fundamentals and holds a Premium valuation at present. Backed by its -37.37% ROE, 0.00% net margin, -12.98 P/E ratio, 10.44 P/B ratio, and -24.34% earnings growth, these metrics solidify its Underperform investment rating.